Regional Biocontainment Laboratory (RBL)
The new Rutgers Regional Biocontainment Laboratory (RBL) on the campus of New Jersey Medical School (NJMS) in Newark, NJ is one of thirteen national facilities designated by the National Institutes of Health (NIH) for research on biosafety level 3 (BSL3) infectious agents. The RBL is a highly secure facility designed to provide an ultra-safe work environment for scientists and support staff, as well as the public at large. The RBL advances the national biomedical research agenda by addressing a basic understanding of pathogen biology and promoting the development of new vaccines, therapeutics and diagnostics against existing and emerging infectious agents. Finally, the RBL is a specialized resource that can aid public health laboratories in the event of an infectious disease emergency.
Current National Biocontainment Laboratories (NBL) and Regional Biocontainment Laboratories (RBL) in the USA
Rutgers RBL
The RBL ..
- was completed and commissioned in Fall 2009;
- supports research objectives of scientists at NJMS, greater Rutgers campuses, and the NIH Region II, Regional Center of Excellence in Biodefense and Emerging Infectious Diseases;
- provides a public health benefit by making expertise and laboratory capacity available to public health authorities in the event of an infectious diseases outbreak to address the need for laboratory surge capacity;
- is an outstanding resource for training scientists and support staff in critical and rapidly expanding areas of science and our country's health defense; and
- helps solidify New Jersey as a major national center of excellence for infectious diseases research
Contact Us
David Alland, MD
